Symbols / HSCS $2.65 -1.11%
HSCS Chart
About
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 8.42M |
| Enterprise Value | 8.91M | Income | -8.49M | Sales | 8.67K |
| Book/sh | 0.83 | Cash/sh | 1.07 | Dividend Yield | — |
| Payout | 0.00% | Employees | 15 | IPO | — |
| P/E | — | Forward P/E | -0.83 | PEG | — |
| P/S | 971.57 | P/B | 3.18 | P/C | — |
| EV/EBITDA | -1.15 | EV/Sales | 1027.89 | Quick Ratio | 0.80 |
| Current Ratio | 1.19 | Debt/Eq | 145.81 | LT Debt/Eq | — |
| EPS (ttm) | -6.56 | EPS next Y | -3.19 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-16 16:00 | ROA | -73.51% |
| ROE | -3.82% | ROIC | — | Gross Margin | 57.92% |
| Oper. Margin | -899.40% | Profit Margin | 0.00% | Shs Outstand | 3.18M |
| Shs Float | 3.07M | Short Float | 1.24% | Short Ratio | 2.48 |
| Short Interest | — | 52W High | 6.47 | 52W Low | 2.01 |
| Beta | — | Avg Volume | 29.94K | Volume | 7.75K |
| Target Price | $10.60 | Recom | None | Prev Close | $2.68 |
| Price | $2.65 | Change | -1.11% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$10.60
Mean price target
2. Current target
$2.65
Latest analyst target
3. DCF / Fair value
$-28.58
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.65
Low
$9.20
High
$12.00
Mean
$10.60
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-12-22 | main | Ascendiant Capital | Buy → Buy | $9 |
| 2025-10-01 | main | Ascendiant Capital | Buy → Buy | $9 |
| 2025-03-18 | main | Ascendiant Capital | Buy → Buy | $14 |
| 2024-12-18 | reit | Maxim Group | Buy → Buy | $12 |
| 2024-09-23 | reit | Ascendiant Capital | Buy → Buy | $15 |
| 2023-01-30 | init | Ascendiant Capital | — → Buy | $3 |
| 2022-12-19 | main | Maxim Group | — → Buy | $3 |
| 2022-11-09 | init | Maxim Group | — → Buy | $8 |
| 2022-08-08 | init | Benchmark | — → Speculative Buy | $8 |
- HeartSciences (NASDAQ: HSCS) seeks approval for larger equity plan and officer shield - Stock Titan ue, 17 Mar 2026 20
- HeartSciences Inc. Reports Fiscal Third Quarter 2026 Financial Results and Progress on MyoVista Insights™ Platform - Quiver Quantitative Mon, 16 Mar 2026 20
- HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance ue, 21 Oct 2025 07
- AI heart scans in the cloud: HeartSciences builds ECG marketplace for hospitals - Stock Titan Mon, 16 Mar 2026 20
- GTN.B Forecast — Price Prediction for 2026. Should I Buy GTN.B? - Intellectia AI Sun, 15 Mar 2026 12
- HeartSciences (NASDAQ: HSCS) posts Q3 loss and flags going concern risk - Stock Titan Mon, 16 Mar 2026 20
- symbol__ Stock Quote Price and Forecast - CNN Mon, 12 Feb 2024 17
- HeartSciences Inc. Reports Second Quarter Fiscal 2026 Financial Results and Progress on MyoVista Insights and wavECG Device Submissions - Quiver Quantitative Mon, 15 Dec 2025 08
- HeartSciences (HSCS) Stock Forecast and Price Target 2026 - MarketBeat hu, 16 May 2024 17
- HeartSciences Inc. (HSCS) - Zacks Investment Research Sat, 11 Jun 2022 16
- Blood across our lifetimes: An age-specific ‘atlas’ tells a dynamic story - Boston Children's Answers Fri, 03 Jan 2025 08
- Special Delivery Nanoparticle Sidesteps the ‘Middlemen’ - Georgia Tech News Center Sat, 21 Dec 2024 08
- A Deep Dive into HeartSciences (HSCS): A Diamond in the Rough - DataDrivenInvestor hu, 29 Feb 2024 08
- HeartSciences (Nasdaq: HSCS) separates device, AI-ECG FDA paths - Stock Titan Mon, 15 Dec 2025 08
- HSCS Stock Price and Chart — NASDAQ:HSCS - TradingView ue, 14 Jun 2022 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 70000 | — | — | Stock Award(Grant) at price 0.00 per share. | SIMPSON ANDREW | Chief Executive Officer | — | 2025-11-28 00:00:00 | D |
| 1 | 4416 | 15621 | — | Sale at price 3.54 per share. | HILZ MARK T | Chief Operating Officer | — | 2025-07-29 00:00:00 | D |
Financials
| Line Item | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -8.14M | -6.16M | -5.98M | -4.68M |
| TotalUnusualItems | 0.00 | 250.20K | 251.86K | |
| TotalUnusualItemsExcludingGoodwill | 0.00 | 250.20K | 251.86K | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -8.77M | -6.61M | -6.35M | -4.83M |
| ReconciledDepreciation | 127.96K | 95.13K | 135.45K | 26.57K |
| ReconciledCostOfRevenue | 1.88K | 6.08K | 2.80K | 7.89K |
| EBITDA | -8.14M | -6.16M | -5.98M | -4.43M |
| EBIT | -8.26M | -6.25M | -6.11M | -4.46M |
| NetInterestIncome | -500.45K | -354.08K | -243.17K | -371.62K |
| InterestExpense | 500.45K | 354.08K | 243.17K | 371.62K |
| NormalizedIncome | -8.77M | -6.61M | -6.35M | -5.08M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -8.77M | -6.61M | -6.35M | -4.83M |
| TotalExpenses | 8.36M | 6.32M | 6.12M | 4.72M |
| TotalOperatingIncomeAsReported | -8.35M | -6.31M | -6.11M | -4.71M |
| DilutedAverageShares | 938.26K | 352.52K | 101.18K | 81.12K |
| BasicAverageShares | 938.26K | 352.52K | 101.18K | 81.12K |
| DilutedEPS | -9.34 | -18.74 | -62.80 | -59.52 |
| BasicEPS | -9.34 | -18.74 | -62.80 | -59.52 |
| DilutedNIAvailtoComStockholders | -8.77M | -6.61M | -6.35M | -4.83M |
| NetIncomeCommonStockholders | -8.77M | -6.61M | -6.35M | -4.83M |
| NetIncome | -8.77M | -6.61M | -6.35M | -4.83M |
| NetIncomeIncludingNoncontrollingInterests | -8.77M | -6.61M | -6.35M | -4.83M |
| NetIncomeContinuousOperations | -8.77M | -6.61M | -6.35M | -4.83M |
| PretaxIncome | -8.77M | -6.61M | -6.35M | -4.83M |
| OtherIncomeExpense | 87.80K | 54.64K | 1.85K | 252.76K |
| OtherNonOperatingIncomeExpenses | 87.80K | 54.64K | 1.85K | 2.56K |
| SpecialIncomeCharges | 0.00 | 250.20K | 251.86K | |
| GainOnSaleOfPPE | 0.00 | 1.66K | ||
| OtherSpecialCharges | -250.20K | -250.20K | ||
| NetNonOperatingInterestIncomeExpense | -500.45K | -354.08K | -243.17K | -371.62K |
| InterestExpenseNonOperating | 500.45K | 354.08K | 243.17K | 371.62K |
| OperatingIncome | -8.35M | -6.31M | -6.11M | -4.71M |
| OperatingExpense | 8.36M | 6.32M | 6.12M | 4.72M |
| ResearchAndDevelopment | 4.39M | 2.88M | 2.46M | 3.00M |
| SellingGeneralAndAdministration | 3.97M | 3.44M | 3.65M | 1.71M |
| GrossProfit | 2.47K | 12.52K | 2.35K | 6.48K |
| CostOfRevenue | 1.88K | 6.08K | 2.80K | 7.89K |
| TotalRevenue | 4.35K | 18.60K | 5.15K | 14.37K |
| OperatingRevenue | 4.35K | 18.60K | 5.15K | 14.37K |
| Line Item | 2023-04-30 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 1.12M | 676.60K | 101.18K | 81.12K |
| ShareIssued | 1.12M | 676.60K | 101.18K | 81.12K |
| NetDebt | 1.45M | 5.15M | 2.16M | |
| TotalDebt | 2.99M | 1.04M | 1.57M | 6.16M |
| TangibleBookValue | -1.41M | 5.73M | 230.18K | -6.06M |
| InvestedCapital | 2.76M | 7.82M | 1.23M | 15.53K |
| WorkingCapital | -1.53M | 5.60M | 863.69K | -1.54M |
| NetTangibleAssets | -1.41M | 5.73M | 230.56K | -6.06M |
| CapitalLeaseObligations | 434.05K | 536.34K | 565.87K | 90.97K |
| CommonStockEquity | 204.79K | 7.32M | 230.18K | -6.06M |
| PreferredStockEquity | 380.00 | 380.00 | 381.00 | 483.00 |
| TotalCapitalization | 205.17K | 7.32M | 730.56K | -1.61M |
| TotalEquityGrossMinorityInterest | 205.17K | 7.32M | 230.56K | -6.06M |
| StockholdersEquity | 205.17K | 7.32M | 230.56K | -6.06M |
| RetainedEarnings | -76.13M | -67.36M | -60.76M | -54.40M |
| AdditionalPaidInCapital | 76.33M | 74.68M | 60.99M | 48.34M |
| CapitalStock | 1.50K | 1.06K | 482.00 | 3.81K |
| CommonStock | 1.12K | 677.00 | 101.00 | 3.32K |
| PreferredStock | 380.00 | 380.00 | 381.00 | 483.00 |
| TotalLiabilitiesNetMinorityInterest | 4.02M | 2.19M | 3.06M | 8.15M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 314.53K | 434.05K | 1.22M | 4.67M |
| NonCurrentAccruedExpenses | 0.00 | 187.45K | 232.87K | 132.23K |
| LongTermDebtAndCapitalLeaseObligation | 314.53K | 434.05K | 1.04M | 4.44M |
| LongTermCapitalLeaseObligation | 314.53K | 434.05K | 536.34K | 0.00 |
| LongTermDebt | 500.00K | 4.44M | 2.50M | |
| CurrentLiabilities | 3.70M | 1.75M | 1.83M | 3.47M |
| OtherCurrentLiabilities | 29.93K | 34.15K | 48.60K | 1.22K |
| CurrentDebtAndCapitalLeaseObligation | 2.67M | 602.29K | 529.53K | 1.72M |
| CurrentCapitalLeaseObligation | 119.52K | 102.29K | 29.54K | 90.97K |
| CurrentDebt | 2.55M | 500.00K | 500.00K | 1.63M |
| OtherCurrentBorrowings | 2.55M | 500.00K | 500.00K | 1.63M |
| PayablesAndAccruedExpenses | 1.00M | 1.12M | 1.25M | 1.75M |
| CurrentAccruedExpenses | 683.93K | 667.14K | 623.39K | 1.05M |
| InterestPayable | 177.63K | 268.81K | 237.53K | |
| Payables | 318.66K | 448.18K | 631.37K | 694.75K |
| AccountsPayable | 318.66K | 448.18K | 631.37K | 694.75K |
| TotalAssets | 4.22M | 9.50M | 3.29M | 2.09M |
| TotalNonCurrentAssets | 2.05M | 2.15M | 590.65K | 158.57K |
| GoodwillAndOtherIntangibleAssets | 1.62M | 1.59M | 0.00 | |
| NetPPE | 435.18K | 559.97K | 590.65K | 158.57K |
| AccumulatedDepreciation | -537.36K | -499.76K | -471.87K | -444.95K |
| GrossPPE | 972.53K | 1.06M | 1.06M | 603.52K |
| Leases | 32.81K | 32.81K | 32.81K | 32.81K |
| OtherProperties | 837.16K | 924.36K | 927.14K | 468.15K |
| MachineryFurnitureEquipment | 102.56K | 102.56K | 102.56K | 102.56K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 2.17M | 7.35M | 2.70M | 1.93M |
| OtherCurrentAssets | 40.37K | 40.37K | 40.37K | 40.37K |
| CurrentDeferredAssets | 290.93K | 692.99K | 175.92K | 246.40K |
| PrepaidAssets | 87.44K | 183.70K | 143.46K | 49.38K |
| Inventory | 650.27K | 629.18K | 676.36K | 674.14K |
| InventoriesAdjustmentsAllowances | -85.58K | -85.58K | -44.48K | -81.45K |
| FinishedGoods | 44.07K | 22.58K | 28.66K | 28.66K |
| WorkInProcess | 21.74K | 21.74K | 21.74K | 21.74K |
| RawMaterials | 670.03K | 670.43K | 670.43K | 705.18K |
| Receivables | 4.35K | 0.00 | 0.00 | 2.32K |
| AccountsReceivable | 4.35K | 0.00 | 0.00 | 2.32K |
| CashCashEquivalentsAndShortTermInvestments | 1.10M | 5.81M | 1.66M | 918.26K |
| CashAndCashEquivalents | 1.10M | 5.81M | 1.66M | 918.26K |
| Line Item | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
| FreeCashFlow | -7.44M | -6.20M | -5.79M | -3.65M |
| RepaymentOfDebt | -264.25K | -291.62K | -398.26K | -500.00K |
| IssuanceOfDebt | 1.85M | 334.25K | 0.00 | 4.73M |
| IssuanceOfCapitalStock | 1.15M | 10.30M | 5.62M | 0.00 |
| CapitalExpenditure | -30.19K | -125.27K | -18.31K | -1.93K |
| EndCashPosition | 1.10M | 5.81M | 1.66M | 918.26K |
| BeginningCashPosition | 5.81M | 1.66M | 918.26K | 723.48K |
| ChangesInCash | -4.71M | 4.15M | 742.21K | 194.78K |
| FinancingCashFlow | 2.73M | 10.34M | 6.53M | 3.84M |
| CashFlowFromContinuingFinancingActivities | 2.73M | 10.34M | 6.53M | 3.84M |
| NetOtherFinancingCharges | -385.14K | |||
| ProceedsFromStockOptionExercised | 0.00 | 1.31M | 0.00 | |
| NetPreferredStockIssuance | 0.00 | 200.00K | ||
| PreferredStockIssuance | 0.00 | 200.00K | ||
| NetCommonStockIssuance | 1.15M | 10.30M | 5.62M | 0.00 |
| CommonStockIssuance | 1.15M | 10.30M | 5.62M | 0.00 |
| NetIssuancePaymentsOfDebt | 1.59M | 42.62K | -398.26K | 4.23M |
| NetShortTermDebtIssuance | 0.00 | 250.20K | ||
| ShortTermDebtIssuance | 0.00 | 250.20K | ||
| NetLongTermDebtIssuance | 1.59M | 42.62K | -398.26K | 4.23M |
| LongTermDebtPayments | -264.25K | -291.62K | -398.26K | -500.00K |
| LongTermDebtIssuance | 1.85M | 334.25K | 0.00 | 4.73M |
| InvestingCashFlow | -30.19K | -125.27K | -18.31K | -1.93K |
| CashFlowFromContinuingInvestingActivities | -30.19K | -125.27K | -18.31K | -1.93K |
| NetIntangiblesPurchaseAndSale | -27.03K | -60.82K | 0.00 | |
| PurchaseOfIntangibles | -27.03K | -60.82K | 0.00 | |
| NetPPEPurchaseAndSale | -3.16K | -64.45K | -18.31K | -1.93K |
| SaleOfPPE | 0.00 | |||
| PurchaseOfPPE | -3.16K | -64.45K | -18.31K | -1.93K |
| OperatingCashFlow | -7.41M | -6.07M | -5.77M | -3.64M |
| CashFlowFromContinuingOperatingActivities | -7.41M | -6.07M | -5.77M | -3.64M |
| ChangeInWorkingCapital | 517.89K | -504.36K | 65.45K | 1.12M |
| ChangeInOtherWorkingCapital | 402.06K | -517.07K | 60.43K | -246.40K |
| ChangeInOtherCurrentLiabilities | -103.51K | -29.53K | -108.54K | 0.00 |
| ChangeInOtherCurrentAssets | 0.00 | |||
| ChangeInPayablesAndAccruedExpense | -112.73K | -241.88K | -272.32K | 1.22M |
| ChangeInAccruedExpense | 16.79K | -58.69K | -310.15K | 865.34K |
| ChangeInPayable | -129.52K | -183.19K | 37.82K | 358.96K |
| ChangeInAccountPayable | -129.52K | -183.19K | 37.82K | 358.96K |
| ChangeInPrepaidAssets | 357.51K | 236.93K | 385.77K | 72.52K |
| ChangeInInventory | -21.09K | 47.18K | -2.22K | 76.64K |
| ChangeInReceivables | -4.35K | 0.00 | 2.32K | -2.32K |
| ChangesInAccountReceivables | -4.35K | 0.00 | 2.32K | -2.32K |
| OtherNonCashItems | 456.51K | 539.23K | 131.51K | 191.72K |
| StockBasedCompensation | 249.88K | 405.02K | 248.31K | 68.40K |
| DepreciationAmortizationDepletion | 127.96K | 95.13K | 135.45K | 26.57K |
| DepreciationAndAmortization | 127.96K | 95.13K | 135.45K | 26.57K |
| AmortizationCashFlow | 0.00 | 644.00 | ||
| AmortizationOfIntangibles | 0.00 | 644.00 | ||
| Depreciation | 127.96K | 95.13K | 135.45K | 26.57K |
| OperatingGainsLosses | -227.31K | -248.54K | ||
| GainLossOnInvestmentSecurities | 22.89K | |||
| GainLossOnSaleOfPPE | 0.00 | 1.66K | ||
| NetIncomeFromContinuingOperations | -8.77M | -6.61M | -6.35M | -4.83M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for HSCS
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|